Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction
CompletedOBSERVATIONAL
Enrollment
41
Participants
Timeline
Start Date
May 31, 2012
Primary Completion Date
October 31, 2012
Study Completion Date
December 31, 2012
Conditions
Acute Myocardial Infarction
All Listed Sponsors
lead
Pharmicell Co., Ltd.
INDUSTRY
NCT01595113 - Safety Study of Clinical Cell Transplant Therapy Using Hearticellgram-AMI for Patients With Acute Myocardial Infarction | Biotech Hunter | Biotech Hunter